Difference between revisions of "Wallace 2010 Annu Rev Pathol"
| Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297-348. | |title=Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297-348. | ||
|info=[https://pubmed.ncbi.nlm.nih.gov/20078222/ PMID: 20078222] | |||
|authors=Wallace DC, Fan W, Procaccio V | |authors=Wallace DC, Fan W, Procaccio V | ||
|year=2010 | |year=2010 | ||
|journal=Annu Rev Pathol | |journal=Annu Rev Pathol | ||
|abstract=Mitochondrial dysfunction has been linked to a wide range of degenerative and metabolic diseases, cancer, and aging. All these clinical manifestations arise from the central role of bioenergetics in cell biology. Although genetic therapies are maturing as the rules of bioenergetic genetics are clarified, metabolic therapies have been ineffectual. This failure results from our limited appreciation of the role of bioenergetics as the interface between the environment and the cell. A systems approach, which, ironically, was first successfully applied over 80 years ago with the introduction of the ketogenic diet, is required. Analysis of the many ways that a shift from carbohydrate glycolytic metabolism to fatty acid and ketone oxidative metabolism may modulate metabolism, signal transduction pathways, and the epigenome gives us an appreciation of the ketogenic diet and the potential for bioenergetic therapeutics. | |||
|editor=Gnaiger E | |||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area=mtDNA;mt-genetics, mt-Medicine, Pharmacology;toxicology | |||
|diseases=Aging;senescence, Cancer | |||
|organism=Human | |||
|additional=BEC 2020.2 | |additional=BEC 2020.2 | ||
}} | }} | ||
== Cited by == | |||
{{Template:Cited by Gnaiger 2020 BEC MitoPathways}} | |||
Revision as of 08:52, 18 June 2021
| Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297-348. |
Wallace DC, Fan W, Procaccio V (2010) Annu Rev Pathol
Abstract: Mitochondrial dysfunction has been linked to a wide range of degenerative and metabolic diseases, cancer, and aging. All these clinical manifestations arise from the central role of bioenergetics in cell biology. Although genetic therapies are maturing as the rules of bioenergetic genetics are clarified, metabolic therapies have been ineffectual. This failure results from our limited appreciation of the role of bioenergetics as the interface between the environment and the cell. A systems approach, which, ironically, was first successfully applied over 80 years ago with the introduction of the ketogenic diet, is required. Analysis of the many ways that a shift from carbohydrate glycolytic metabolism to fatty acid and ketone oxidative metabolism may modulate metabolism, signal transduction pathways, and the epigenome gives us an appreciation of the ketogenic diet and the potential for bioenergetic therapeutics.
• Bioblast editor: Gnaiger E
Labels: MiParea: mtDNA;mt-genetics, mt-Medicine, Pharmacology;toxicology
Pathology: Aging;senescence, Cancer
Organism: Human
BEC 2020.2
Cited by
- Gnaiger E (2020) Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis. 5th ed. Bioenerg Commun 2020.2. https://doi.org/10.26124/bec:2020-0002
